Search results
Results From The WOW.Com Content Network
Biotronik (BIOTRONIK SE & Co. KG; [1] [2] Biotronik Worldwide) is a limited partnership [1] multi-national cardiovascular biomedical research and technology company, headquartered in Berlin, Germany. The company offers equipment for diagnosis, treatment, and therapy support in the areas of cardiac rhythm management, electrophysiology , and ...
The following are medications commonly prescribed cardiac pharmaceutical agents. The specificity of the following medications is highly variable, and often are not particularly specific to a given class. As such, they are listed as are commonly accepted.
All patients are reviewed for contraindications prior to MRI scanning. Medical devices and implants are categorized as MR Safe, MR Conditional or MR Unsafe: [6] MR-Safe – The device or implant is completely non-magnetic, non-electrically conductive, and non-RF reactive, eliminating all of the primary potential threats during an MRI procedure.
Patients with pacemakers in the U.S. had previously been dissuaded from using MRIs before Medtronic's first SureScan MRI-compatible pacemaker won approval a few years ago. Accoridng to Medtronic's ...
Osteoporosis, including drug- and cancer-related osteoporosis, giant cell tumour of bone and hypercalcaemia of malignancies: Hypercholesterolaemia, cataract, urinary retention, hypocalcaemia, osteonecrosis of the jaw and anaphylaxis. Gemtuzumab ozogamicin: IV: CD33 antibody that induces apoptosis of the tagged cell. Acute myeloid leukaemia
The ILR is a useful diagnostic tool to investigate patients who experience symptoms such as syncope (fainting), seizures, recurrent palpitations, lightheadedness, or dizziness not often enough to be captured by a 24-hour or 30-day external monitor.
For premium support please call: 800-290-4726 more ways to reach us
By early 1973, over 60 implanted Betacel-Biotronik pacemakers were being monitored as part of the clinical investigation. [ 3 ] [ 6 ] By mid-1974, the USAEC had authorized the licensing in the United States of a Clinical Investigation Program that allowed the implantation of 50 Betacel-Biotronik pacemakers per month in major clinics in the U.S ...